NCT07139392

Brief Summary

The interdental papilla, a small wedge of gingival tissue positioned between adjacent teeth, plays a crucial role in both dental esthetics and oral function. Loss or deficiency of the papilla results in the formation of "black triangles," which not only compromise a patient's smile but also lead to challenges such as food impaction, phonetic difficulties, and increased risk of periodontal disease. The reconstruction of the interdental papilla is recognized as one of the most challenging procedures in periodontal therapy, particularly when aiming for enhanced esthetic outcomes and patient satisfaction

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2025

Shorter than P25 for phase_3

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2025

Completed
Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

19 days

First QC Date

August 17, 2025

Last Update Submit

August 17, 2025

Conditions

Keywords

ALB-PRFpapillaconnective tissuereconstructionMINST

Outcome Measures

Primary Outcomes (1)

  • Papilla Height Gain

    Papilla Height Gain (measured from contact point to papilla tip)

    6 months follow up

Study Arms (2)

connective tissue graft

PLACEBO COMPARATOR

Semi-lunar flap elevation, then connective tissue graft sutured under the flap for papilla reconstruction

Biological: connective tissue graft

albumin-PRF

ACTIVE COMPARATOR

Albumin- PRF for papilla reconstruction

Biological: Albumin (5% serum-protein solution containing immunoglobulins)

Interventions

* Preoperative Phase: * Oral hygiene instruction * Phase I periodontal therapy * Initial photography and papillary height measurements using digital calipers or customized stents * Surgical Technique: * Local anesthesia * Intrasulcular incision around target teeth * Papilla preservation flap * Harvesting CTG from the palate * Injection of liquid Bio-PRF at the papillary base (test group) * CTG positioned in the papilla region * Suturing with microsurgical technique * Postoperative Protocol: * Analgesics (e.g., ibuprofen 400 mg) * Chlorhexidine 0.12% mouth rinse for 2 weeks * Suture removal at 10-14 days * Follow-up at 1 month, 3 months, and 6 months

Also known as: alb-prf
albumin-PRF

Local anesthesia. Intrasulcular incision around target teeth. Papilla preservation flap. Harvesting CTG from the palate

connective tissue graft

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-55 years
  • Nordland and Tarnow Class I/II papillary loss
  • Good oral hygiene (FMPS \& FMBS \<20%)
  • Systemically healthy

You may not qualify if:

  • Smoking
  • Periodontal pockets \>4 mm in the target site
  • History of systemic diseases or medications affecting healing
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Albumins

Intervention Hierarchy (Ancestors)

ProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • shaimaa Hamdy, lecturer

    lecturer of periodontology Nahda University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

shaimaa Hamdy, lecturer of Periodontology

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Sample Selection: * Inclusion Criteria: * Age 20-55 years * Nordland and Tarnow Class I/II papillary loss * Good oral hygiene (FMPS \& FMBS \<20%) * Systemically healthy * Exclusion Criteria: * Smoking * Periodontal pockets \>4 mm in target site * History of systemic diseases or medications affecting healing * Pregnant or lactating women * Preoperative Phase: * Oral hygiene instruction * Phase I periodontal therapy * Initial photography and papillary height measurements using digital calipers or customized stents * Surgical Technique: * Local anesthesia * Intrasulcular incision around target teeth * Papilla preservation flap * Harvesting CTG from the palate * Injection of liquid Bio-PRF at the papillary base (test group) * CTG positioned in the papilla region * Suturing with microsurgical technique * Postoperative Protocol: * Analgesics (e.g., ibuprofen 400 mg) * Chlorhexidine 0.12% mouth rinse for 2 weeks * Suture removal at 10-14 days * Follow-up
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
lecturer of oral medicine, oral diagnosis and periodontology

Study Record Dates

First Submitted

August 17, 2025

First Posted

August 24, 2025

Study Start

September 1, 2025

Primary Completion

September 20, 2025

Study Completion

September 23, 2025

Last Updated

August 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

After completing the study, I will share all the data of the study